Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, View ORCID ProfileAhmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
doi: https://doi.org/10.1101/2021.11.20.21266229
Hossein Faramarzi
1Department of Community Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Amirhossein Sahebkar
2Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran E-mail address:
3Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
Ahmad Hosseinpour
4Shimi Teb Salamat Co., Shiraz, Iran. E-mail address:
Vahid Khaloo
5Ali Asghar Hospital, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Parisa Chamanpara
6Department of Biostatistics, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Mohammad Reza Heydari
7Shiraz HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. E-mail address:
Sajad Najafi
8Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. E-mail address:
Fatemeh Fotoohi Khankahdany
4Shimi Teb Salamat Co., Shiraz, Iran. E-mail address:
Ahmad Movahedpour
9Behbahan Faculty of Medical Sciences, Behbahan, Iran. E-mail address:

Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Posted November 25, 2021.
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Hossein Faramarzi, Amirhossein Sahebkar, Ahmad Hosseinpour, Vahid Khaloo, Parisa Chamanpara, Mohammad Reza Heydari, Sajad Najafi, Fatemeh Fotoohi Khankahdany, Ahmad Movahedpour
medRxiv 2021.11.20.21266229; doi: https://doi.org/10.1101/2021.11.20.21266229
Subject Area
Subject Areas
- Addiction Medicine (227)
- Allergy and Immunology (502)
- Anesthesia (110)
- Cardiovascular Medicine (1234)
- Dermatology (147)
- Emergency Medicine (282)
- Epidemiology (10015)
- Gastroenterology (499)
- Genetic and Genomic Medicine (2448)
- Geriatric Medicine (236)
- Health Economics (479)
- Health Informatics (1638)
- Health Policy (751)
- Hematology (248)
- HIV/AIDS (532)
- Medical Education (252)
- Medical Ethics (74)
- Nephrology (268)
- Neurology (2277)
- Nursing (139)
- Nutrition (350)
- Oncology (1245)
- Ophthalmology (375)
- Orthopedics (133)
- Otolaryngology (226)
- Pain Medicine (155)
- Palliative Medicine (50)
- Pathology (324)
- Pediatrics (729)
- Primary Care Research (282)
- Public and Global Health (4829)
- Radiology and Imaging (834)
- Respiratory Medicine (650)
- Rheumatology (283)
- Sports Medicine (226)
- Surgery (266)
- Toxicology (44)
- Transplantation (125)
- Urology (99)